ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 174 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2019. The put-call ratio across all filers is 0.88 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $635,000 | -22.5% | 17,327 | -1.6% | 0.02% | -24.1% |
| Q2 2019 | $819,000 | -9.4% | 17,611 | -21.8% | 0.03% | -25.6% |
| Q1 2019 | $904,000 | -8.9% | 22,520 | +4.4% | 0.04% | -35.0% |
| Q4 2018 | $992,000 | -13.3% | 21,580 | -16.3% | 0.06% | +7.1% |
| Q3 2018 | $1,144,000 | +717.1% | 25,786 | +618.9% | 0.06% | +700.0% |
| Q2 2018 | $140,000 | -94.3% | 3,587 | -89.5% | 0.01% | -95.9% |
| Q1 2018 | $2,472,000 | +347.0% | 34,180 | +307.2% | 0.17% | +391.4% |
| Q4 2017 | $553,000 | -22.4% | 8,394 | -41.0% | 0.04% | -12.5% |
| Q3 2017 | $713,000 | -4.3% | 14,217 | -11.7% | 0.04% | 0.0% |
| Q2 2017 | $745,000 | -1.1% | 16,094 | -24.5% | 0.04% | +2.6% |
| Q1 2017 | $753,000 | +182.0% | 21,325 | 0.0% | 0.04% | +143.8% |
| Q4 2016 | $267,000 | -9.5% | 21,325 | 0.0% | 0.02% | -33.3% |
| Q3 2016 | $295,000 | -90.0% | 21,325 | -62.0% | 0.02% | -80.6% |
| Q2 2016 | $2,938,000 | +58.9% | 56,063 | -48.7% | 0.12% | +96.8% |
| Q1 2016 | $1,849,000 | -31.1% | 109,360 | -9.3% | 0.06% | -25.9% |
| Q4 2015 | $2,684,000 | -16.1% | 120,555 | -11.1% | 0.08% | +19.7% |
| Q3 2015 | $3,198,000 | -71.1% | 135,555 | 0.0% | 0.07% | -67.7% |
| Q2 2015 | $11,083,000 | +8.7% | 135,555 | +23.1% | 0.22% | +5.8% |
| Q1 2015 | $10,195,000 | – | 110,100 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 2,629,835 | $116,685,000 | 25.08% |
| Aviva Holdings Ltd. | 1,200,100 | $53,248,000 | 14.21% |
| Boxer Capital, LLC | 1,375,000 | $61,009,000 | 6.77% |
| BB BIOTECH AG | 3,282,964 | $145,665,000 | 3.86% |
| Rhenman & Partners Asset Management AB | 353,961 | $15,705,000 | 1.57% |
| PFM Health Sciences, LP | 1,970,134 | $87,415,000 | 1.28% |
| Bellevue Group AG | 391,852 | $17,386,000 | 1.10% |
| Pentwater Capital Management LP | 2,351,500 | $104,336,000 | 0.88% |
| Partner Investment Management, L.P. | 25,440 | $1,129,000 | 0.86% |
| SABBY MANAGEMENT, LLC | 100,369 | $4,453,000 | 0.57% |